Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019)
Amneal Pharmaceuticals (AMRX) posted quarterly Current Taxes of $8.7 million for Q4 2019, up 653.15% year-over-year from $1.2 million in Q4 2018, and up 653.15% quarter-over-quarter from $1.2 million in Q4 2018.
Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019) Analysis & Trends
Amneal Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $8.7 million for Q4 2019.
- In Q4 2019, Current Taxes rose 653.15% year-over-year to $8.7 million; the TTM figure through Dec 2019 stood at $8.7 million (up 653.15% YoY), while the FY2019 annual figure was $8.7 million, up 653.15% from the prior year.
- Current Taxes for Q4 2019 stood at $8.7 million, up from $1.2 million in the prior quarter.
- The five-year high for Current Taxes was $8.7 million in Q4 2019, with the low at $1.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 46.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8.73 Mn |
| Dec 31, 2018 | 1.16 Mn |